leisure time -WSS

leisure time

author：knowledge 2025-09-06 04:35:38 - browse：8733

Illustration of doctor with an computer text bubble for a face for a story on Chat GPT and AI – health tech coverage from STAT — Mike Reddy for STAT

Health care companies are racing to incorporate generative AI tools into their product pipelines and IT systems after the technology displayed an ability to perform many tasks faster, cheaper — and sometimes better — than humans.

But the rush to harness the power of so-called large language models, which are trained on vast troves of data, is outpacing efforts to assess their value. AI experts are still trying to understand, and explain, how and why they work better than prior systems, and what blind spots might undermine their usefulness in medicine.

It remains unclear, for example, how well these models will perform, and what privacy and ethical quandaries will arise, when they’re exposed to new types of data, such as genetic sequences, CT scans, and electronic health records. Even knowing exactly how much data must be fed into a model to achieve peak performance on a given task is still largely guesswork.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Ukraine and a new approach to mental health in war

Wikipedia

WSS

Second xenotransplant done with gene

Setback for rare diseases as Taysha Gene Therapies pulls back

Biotech lab space demand falls sharply

What we owe ALS patients — and why one company fell short

Stop Congress from blocking public access to science

Setback for rare diseases as Taysha Gene Therapies pulls back

focus

leisure time

leisure time

What does generative AI mean for health care? We asked experts

Experts study whether long Covid risk adds up with each reinfection

Medicare details structure of new drug price negotiation program

Stop Congress from blocking public access to science

Bright Health sells Medicare Advantage business to Molina

RSV injection headlines need to be accurate for good uptake

Wildfire smoke exposes gaps in outdoor worker protections

Changes to biosimilar regulatory framework must prioritize patients

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

STAT Virtual Event: Putting AI to the Test

focus

The biotech scorecard for Q4: 16 stock

IVG is promising — but it won’t replace IVF quite yet

RSV injection headlines need to be accurate for good uptake

Biotech stock slump in 2023: awaiting the turnaround

CDC's new outbreak response network to include Northeastern

Biotech lab space demand falls sharply

explore

focus

Wikipedia

hotspot